Global and regional pooled <i>Giardia</i> infection prevalence rates in nonhuman mammalian hosts. Results from 1,632 datasets from 89 countries. Countries were grouped according to... by Kareem Hatam-Nahavandi (7384790)

Subjects:

(A-B): Mean intraocular pressure (IOP) (A) and mean number of glaucoma medications (B) with standard deviations are shown for XEN (grey) and PRESERFLO (black) groups at baseline (p... by Cemre Altas (22537656)

Segmented regression analysis of time to intravenous antimicrobial administration (IVA) at intervention and control sites during the implementation period. by J Mark Ansermino (13958512)

Subjects:

Interrupted time series analysis showing time to intravenous antimicrobials (IVA) in minutes at intervention and control sites in Uganda during baseline and implementation periods. by J Mark Ansermino (13958512)

Subjects:

Kenya: Enrolment, time to IVA, mortality, admissions and readmissions at sites in Kenya. by J Mark Ansermino (13958512)

Subjects:

Uganda: enrolment, time to IVA, mortality, admissions and readmissions. by J Mark Ansermino (13958512)

Subjects:

Interrupted time series analysis showing time to intravenous antimicrobials (IVA) in minutes at intervention and control sites in Kenya during baseline and implementation periods. by J Mark Ansermino (13958512)

Subjects:

Flow diagram of the Smart Triage multisite interventional study in Uganda and Kenya indicating the progress through study phases at each site. by J Mark Ansermino (13958512)

Subjects:

Data. by Michael C. Payne (2664379)

Subjects:

Flowchart of the screening process. by Huixia Ren (500186)

“…Using PRISMA 2020, the “Yes” response rate for Q5, Q8, and Q15 was below 55 percent. Per ROBIS, all SRs/MAs exhibited low risk in phase 1 and domain 1 but high risk in domain 2. …”

Result of the AMSTAR-2 assessments. by Huixia Ren (500186)

“…Using PRISMA 2020, the “Yes” response rate for Q5, Q8, and Q15 was below 55 percent. Per ROBIS, all SRs/MAs exhibited low risk in phase 1 and domain 1 but high risk in domain 2. …”

Characteristics of included reviews. by Huixia Ren (500186)

“…Using PRISMA 2020, the “Yes” response rate for Q5, Q8, and Q15 was below 55 percent. Per ROBIS, all SRs/MAs exhibited low risk in phase 1 and domain 1 but high risk in domain 2. …”

Result of the PRISMA assessments. by Huixia Ren (500186)

“…Using PRISMA 2020, the “Yes” response rate for Q5, Q8, and Q15 was below 55 percent. Per ROBIS, all SRs/MAs exhibited low risk in phase 1 and domain 1 but high risk in domain 2. …”

Result of the ROBIS assessments. by Huixia Ren (500186)

“…Using PRISMA 2020, the “Yes” response rate for Q5, Q8, and Q15 was below 55 percent. Per ROBIS, all SRs/MAs exhibited low risk in phase 1 and domain 1 but high risk in domain 2. …”

Prescription data. by Dainty Ei (22265317)

Subjects:

Phenotype analysis of PbPP6-GFP parasites. by Yonghui Feng (12227596)

The sexual stage phenotype of <i>pbpp6</i> gene knockout clones. by Yonghui Feng (12227596)

Ultrafine Particulate Matter Exacerbates the Risk of Delayed Neural Differentiation: Modulation Role of METTL3-Mediated m⁶A Modification by Rui Wang (52434)

Subjects:

Median ± IQR <i>M. plutonius</i> bacterial load (CFU/bee) of newly emerged summer worker bees inoculated with 1 × 10⁷ CFU/bee <i>M. plutonius</i> 2019BC1 and/or treated... by Midhun Sebastian Jose (19336846)

Overexpression <i>TRIM37</i> promotes myelin repair and inhibits cell apoptosis by upregulating PEX5. by Lai Jiang (2401513)

Subjects: